Cladribine, gemcitabine, busulfan and SAHA combination as a potential pre-transplant conditioning regimen for lymphomas: a preclinical study

Hematopoietic stem cell transplantation (HSCT) is an effective treatment for patients with refractory lymphomas. Nucleoside analogues (NA) and DNA alkylating agents are efficacious in treating hematologic malignancies. To design an efficacious and more economical pre-transplant regimen for lymphoma...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Exp Hematol
Main Authors: Ji, Jie, Valdez, Benigno C., Li, Yang, Liu, Yan, Teo, Esmeralda C., Nieto, Yago, Champlin, Richard E., Andersson, Borje S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4864055/
https://ncbi.nlm.nih.gov/pubmed/26976752
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.exphem.2016.03.001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados